Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Acinetobacter Infections
/ drug therapy
Acinetobacter baumannii
/ drug effects
Animals
Anti-Bacterial Agents
/ therapeutic use
Bacterial Load
Bacterial Outer Membrane
/ drug effects
Biofilms
/ drug effects
Burns
/ drug therapy
Drug Resistance, Multiple, Bacterial
Drug Synergism
Drug Therapy, Combination
Female
Lysine
/ analogs & derivatives
Mice
Mice, Inbred BALB C
Microbial Sensitivity Tests
Pseudomonas Infections
/ drug therapy
Pseudomonas aeruginosa
/ drug effects
Rifampin
/ therapeutic use
Tetracycline
/ therapeutic use
Wound Infection
/ drug therapy
Gram-negative superbugs
antibiotic-resistance
biofilms
burn-wound infections
combination therapy
membrane-targeting compound
Journal
ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580
Informations de publication
Date de publication:
10 01 2020
10 01 2020
Historique:
pubmed:
28
10
2019
medline:
15
12
2020
entrez:
25
10
2019
Statut:
ppublish
Résumé
The priority pathogen list published by the World Health Organization (WHO) has categorized carbapenem-resistant
Identifiants
pubmed: 31646866
doi: 10.1021/acsinfecdis.9b00221
doi:
Substances chimiques
Anti-Bacterial Agents
0
Tetracycline
F8VB5M810T
Lysine
K3Z4F929H6
Rifampin
VJT6J7R4TR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM